Vertex Pharmaceuticals CEO and key executive team
Vertex Pharmaceuticals's Executive Chairman is Jeffrey Leiden. Vertex Pharmaceuticals's key executives include Jeffrey Leiden and 18 others.
Jeffrey Leiden
Executive Chairman
Reshma Kewalramani
Chief Executive Officer, President & Director
Sangeeta N. Bhatia
Director
David Altshuler
Executive Vice President, Global Research and Chief Scientific Officer
Carmen Bozic
Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer
Stuart A. Arbuckle
Executive Vice President and Chief Commercial Officer
Amit K. Sachdev
Executive Vice President and Chief Patient Officer
Michael J. Parini
Executive Vice President, Chief Administrative, Legal and Business Development Officer
Charles F. Wagner
Executive Vice President and Chief Financial Officer
Bastiano Sanna
Executive Vice President, Chief of Cell and Genetic Therapies and VCGT Site Head
Mark Bunnage
Senior Vice President and Site Head, Boston Research
Nina Devlin
Senior Vice President and Chief Communications Officer
Nia Tatsis
Executive Vice President and Chief Regulatory and Quality Officer
Stephanie Franklin
Senior Vice President and Chief Human Resources Officer
Ludovic Fenaux
Senior Vice President, International Commercial Operations
Paul Negulescu
Senior Vice President and Site Head, San Diego Research
Mike Tirozzi
Senior Vice President and Chief Information & Data Officer
Damian Wilmot
Senior Vice President, Chief Risk and Compliance Officer
Michael Partridge
Senior Vice President, Investor Relations
Source:global.vrtx.com, global.vrtx.com, vrtx.com, vrtx.com, vrtx.com, vrtx.com, vrtx.com, vrtx.com, vrtx.com, vrtx.com
Last updated:
Key Executive Tracking
Receive notifications of key executive changes
